MannKind makes $12.5M pharma buy
MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →
UV light startup helps restaurants go antiviral
As a result of the COVID-19 pandemic, owners of all sorts of businesses are looking at an option for disinfecting surfaces that has long been dismissed as too expensive to use outside of hospitals: UV-C technology.
Trade Desk ceiling keeps getting higher
The Trade Desk continues its ascent towards the $1,000 mark, as the torrid stock closed at $890.13 Dec. 1—up 516% since its year low in mid-March.
Semtech reaches record highs after earnings beat
Semtech, a Camarillo semiconductor company specializing in Internet of Things applications, announced earnings on Dec. 2 that beat both the previous quarter and analysts’ estimates. Shares of Semtech were trading at just under $70 my midday on Dec. 3, the highest stock price in the company’s history. The company’s shares are up 23% in the Read More →
PureSpectrum headlines region’s companies on Deloitte’s Fast 500
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Gig companies benefit from ballot measure
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen joins new cooperative trials for COVID treatment
With COVID-19 continuing to surge across the globe, a coalition of pharmaceutical companies including Thousand Oaks-based Amgen has announced a joint trial for new coronavirus treatments. Amgen, along with Takeda and UCB, are now collaborating to study methods of treatment for patients who are hospitalized due to COVID-19, the three companies announced. The trial enrolled Read More →
